The High Content Screening market was valued at US$ 1,670.96 million in 2022 to US$ 2,861.56 million by 2030; it is estimated to record a CAGR of 7.2% from 2022 to 2030.
Market Insights and Analyst View:
High-content screening (HCS) is a high-throughput format for cell biology applications that combines quantitative data analysis and automated imaging for large-scale applications, including systems biology and drug discovery. Currently, HCS mostly serves as a fluorescence imaging technique, usually simultaneously measuring a small number of fluorochromes. The drug discovery industry has witnessed a significant surge in the use of HCS due to advancements in automated screening technologies and fluorescence microscopy in recent years. Using an automated fluorescence microscope to image individual cells' subcellular and molecular activities, HCS offers the possibility of quickly screening chemical or siRNA libraries. The most obvious uses of HCS are in primary screenings for possible leads, compounds that can be further refined into therapeutic candidates, or in measures of cellular morphology or other cellular activities that are difficult to measure with a single endpoint, including spatially localized proteins.
Growth Drivers and Challenges:
An increase in research and development activities is driving growth in the market. High-content screening provides biological answers to academic and pharmaceutical questions. Hepatotoxicity, cardiotoxicity, nephrotoxicity, developmental toxicity, genotoxicity, and neurotoxicity are in vitro toxicology applications that employ HCS methodologies. This makes several recently created cellular assay models possible, such as tissues-on-a-chip methods, three-dimensional (3D) cell models, and induced pluripotent stem cells (iPSCs). HCS is also utilized via image data analysis tools, coupling with high-content assays, and genome editing methods (e.g., CRISPR/Cas9). These methods significantly advance understanding biological processes, creating medications, and simplifying toxicological research.
The HCS market is expanding globally due to research and development in drug discovery. For example, Purdue University, a public land-grant research university, published a report in February 2020 evaluating the impact of IL-27, a heterodimeric cytokine made up of subunits IL-27p28 and EBI3 (Epstein-Barr virus-induced gene 3), on alterations in the gene expression of TC2R prostate adenocarcinoma cells. The TC2R prostate cancer cells' gene expression was altered by RNAi (RNA interference), which was found using high-throughput sequencing (HCS). RNAi targets messenger RNAs that code for those particular proteins.
Despite the enormous processing power, fast connectivity, and reasonably priced data storage that are accessible with modern computers, there are still several important technological challenges that must be made while applying HCS. HCS practitioners frequently discover that third-party analysis software is required to enhance the efficiency of an infrequent test, even though many instruments come with strong, user-friendly image analysis software. In addition, many solutions for data storage, data transfer, and data annotation do not transition well between platforms since there is a lack of standards for image and data formats.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
High Content Screening Market: Strategic Insights
Market Size Value in US$ 1,670.96 million in 2022 Market Size Value by US$ 2,861.56 million by 2030 Growth rate CAGR of 7.2% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
High Content Screening Market: Strategic Insights
Market Size Value in | US$ 1,670.96 million in 2022 |
Market Size Value by | US$ 2,861.56 million by 2030 |
Growth rate | CAGR of 7.2% from 2022 to 2030 |
Forecast Period | 2022-2030 |
Base Year | 2022 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to AnalystReport Segmentation and Scope:
The high content screening market is segmented into product, application, and end user. By product, the market is segmented into instruments, consumables, software, services, and accessories. By application, the high-content screening market is categorized into primary screening and secondary screening, target identification and validation, toxicity studies, compounds, and others. In terms of end users, the high-content screening market is segmented into pharmaceutical and biotechnology companies, contract research organizations (CROs), and academic and government institutes. The high content screening market, based on geography, is categorized into North America (US, Canada, and Mexico), Europe (France, Germany, Italy, UK, Spain, Benelux, Austria, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, Malaysia, Indonesia, and Rest of Asia Pacific), Middle East & Africa (Saudi Arabia, UAE, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, Rest of South & Central America)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Segmental Analysis:
Based on product, the global high-content screening market is segmented into instruments, consumables, software, services, and accessories. The instruments segment held the largest share of the market in 2022. Since high-content screening technologies are used to visualize and interpret cellular images, they are essential for toxicology, drug development, and basic cell biology research. These state-of-the-art devices have many features, such as high throughput capability, automated imaging and analysis, and the ability to do difficult experiments.
High-content screening software is used in picture analysis, data management, and assay design. The time and cost of manual analysis can be reduced using sophisticated software that can automate certain high-content screening processes, thanks to artificial intelligence and machine learning breakthroughs. A further factor contributing to the expected strong demand for high-content screening software is the growing interest in precision and personalized medicine, which can assist in creating medicines specifically tailored to individual patients' needs.
By application, the high-content screening market is segmented into target identification and validation, primary screening and secondary screening, toxicity studies, compounds, and others. 2022 the toxicity studies segment is estimated to grow at the highest CAGR. Because high-content screening can identify compounds that damage cells, it is essential for toxicity investigations. A range of tests can be performed to assess a substance's effects on cell viability, proliferation, and apoptosis. Software and technologies for high-content screening can be used for these assays. Furthermore, high-content screening helps researchers identify any safety concerns early in the drug development process by examining the toxicity processes of chemicals.
By end user, the high content screening market is categorized into academic and government institutes, pharmaceuticals and biotechnology companies, and contract research organizations (CROs). The pharmaceuticals and biotechnology companies segment held the largest share of the market in 2022. High-content screening dominates this market because the biotechnology and pharmaceutical industries utilize it extensively in preclinical and clinical investigations. Its use in academia and the pharmaceutical industry has grown to the point where it is now a vital tool for drug research and discovery. High-content assays have a greater potential to aid in drug development now that cellular assay technologies have advanced to the point where three-dimensional (3D) cultures, genome editing tools (e.g., CRISPR/Cas9), and induced pluripotent stem cells (iPSCs).
High Content Screening Market, by Product – 2022 and 2030
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Regional Analysis:
Based on geography, the high content screening market is categorized into five key regions—North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. Asia Pacific is anticipated to register the highest CAGR during the forecast period. As a result of the growing need for drug research and development in emerging countries such as China and India, the high-content screening products market in the Asia Pacific is expected to grow quickly.
High Content Screening Market Trend:
Automated Microscope Based High Content Screening
Automated microscope-based high-content screening has gained substantial momentum recently due to its capability to study many features simultaneously in complicated biology systems. HCS is used all along the preclinical drug discovery pipeline. It can identify and validate new drug targets or lead compounds, predict in vivo toxicity, and suggest pathways or molecular targets of compounds. HCS also used to support clinical trials, such as companion diagnostics. Consequent High-Content Screening (HCS) solutions for testing the possible toxicity of chemicals and complicated substances are being implemented by pharmaceutical companies to improve in-vitro toxicity testing by reducing the cost and time. The increasing number of CROs providing HCS outsourcing services and applying HCS in personalized medicine presents a significant trend in the market. High-content screening microscopy is a rapidly evolving technology that can be applied to extract rich quantitative information about cell form and function.
Competitive Landscape and Key Companies:
A few of the prominent players operating in the global high content screening market are GE Healthcare, Danaher Corporation, Thermo Fisher Scientific Inc., PerkinElmer, Tecan Group, Bio Tek Instruments Inc., Becton, Dickinson, Bio-Rad Laboratories, Yokogawa Electric Corporation, and Merk Millipore. These companies focus on developing new technologies, advancing existing products, expanding their geographic footprint to meet the growing consumer demand worldwide, and expanding their product range in specialty portfolios. Companies operating in the global high-content screening market implement various inorganic and organic strategies. A few of them are mentioned below:
- In September 2022, BD (Becton, Dickinson, and Company) launched BD Research Cloud, a cloud-based software solution intended to streamline the flow cytometry workflow to empower higher-quality experiments with faster time to insight for scientists working across a range of disciplines, including virology, immunology, oncology, and infectious disease monitoring.
- In March 2022, Beckman Coulter Life Sciences introduced a powerful solution to manual sample preparation and data management bottlenecks in clinical flow cytometry: the CellMek SPS. This fully automated sample preparation system (SPS) offers on-demand processing for many sample types to help laboratories expand their capabilities.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Application, End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. GENERAL ELECTRIC
2. Danaher
3. Perkinelmer, Inc.
4. Thermo Fisher Scientific Inc.
5. BD
6. BioTek Instruments, Inc.
7. Bio-Rad Laboratories, Inc.
8. Tecan Trading AG
9. Merck KGaA
10. Yokogawa Electric Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to High Content Screening Market
Apr 2024
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2024
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2024
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2024
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Apr 2024